GlassScriptPhysician profile
Christopher H Schank
NPI 1134534647
$13,450.90
in general payments reported to CMS, 2019-2025
7 companies · $7,220 in 2025
The $7,220 reported for 2025 was more than what 95% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,000 · 2020: $1,014 · 2022: $58.30 · 2023: $138 · 2024: $1,020 · 2025: $7,220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,200 · Travel and Lodging: $693 · Food and Beverage: $486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,200.00 |
| Travel and Lodging | $692.54 |
| Food and Beverage | $485.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kuros Biosciences USA, INC | $7,221.84 | 2024-2025 | Magnetos |
| Arthrex, INC. | $5,199.10 | 2019-2024 | |
| Novus Surgical Consultants | $782.43 | 2024 | |
| Organogenesis INC. | $124.59 | 2023 | Puraply |
| Smith+Nephew, INC. | $89.54 | 2022-2024 | Collagenase Santyl |
| Ossdsign USA Incorporated | $19.72 | 2025 | Ossdsign Catalyst |
| Djo, LLC | $13.68 | 2023 | Cmf |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Schank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.